Abdul qadeer1, Khatidja Ally1, Hira Waseem1, Hina Rajani1, Ashar Masood Khan2.
1National institute of child health, Karachi, Pakistan, 2Dr Ziauddin University hospital, Karachi, Pakistan.
Show affiliations
|
Abstract
SARS-Cov-2, commonly known as severe acute respiratory syndrome, is primarily asymptomatic or mild in severity in children, as documented by the COVID-19 spread.1 A unique problem during this worldwide outbreak has been the emergence of "multi-system inflammatory syndrome in children (MIS-C), a rare post-infectious hyper-inflammatory disorder associated with SARS-CoV-2". The patient can present with characteristics such as signs of congestive heart failure, pyrexia, hypotension, and inflammatory conditions. Additionally, this illness has features similar to toxic shock syndrome (TSS), macrophage activation syndrome (MAS), and Kawasaki disease (KD). The purpose of this report is outlining the presenting characteristics, suspected immunopathogenesis, treatment, and prognosis of MIS-C patients.
|